DNLI CapEx to Revenue
Denali Therapeutics Inc · CapEx to Revenue
DNLI CapEx to Revenue
Current (TTM)94.81%retrieved
DNLI CapEx/Revenue (0.00% → 94.81%)
Latest values, visible window
High-resolution chart · PNG
DNLI capex to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0% | |
| 0% | |
| 3.9146% | |
| 16.4416% | |
| 17.4678% | |
| 0.9221% | |
| 67.1677% | |
| 2.627% | |
| 0% | |
| 0% | |
| 0% |